Covered recipient · General Payments record
DAVID P KELSEN
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2019–2024
$110,493.39
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $29,194.25 | 7 |
| Travel and Lodging | $108.54 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $8,713.25 | 4 |
| E.R. Squibb & Sons, L.L.C. | $8,239.54 | 2 |
| Janssen Research & Development, LLC | $6,300.00 | 1 |
| ABBVIE INC. | $6,050.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6,050.00 | 10/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103135995 | CMS |
| E.R. Squibb & Sons, L.L.C. | $8,131.00 | 08/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101482297 | CMS |
| E.R. Squibb & Sons, L.L.C. | $108.54 | 09/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1101482301 | CMS |
| Janssen Research & Development, LLC | $6,300.00 | 02/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077590171 | CMS |
| Merck Sharp & Dohme LLC | $2,115.75 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141826970 | CMS |
| Merck Sharp & Dohme LLC | $2,730.00 | 06/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141574031 | CMS |
| Merck Sharp & Dohme LLC | $1,933.75 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141574033 | CMS |
| Merck Sharp & Dohme LLC | $1,933.75 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141574035 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.